Cutler Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$416K Hold
1,915
0.11% 89
2025
Q4
$438K Hold
1,915
0.13% 94
2025
Q3
$443K Buy
1,915
+8
+0.4% +$1.63K 0.14% 90
2025
Q2
$354K Sell
1,907
-212
-10% -$39.4K 0.12% 89
2025
Q1
$444K Sell
2,119
-281
-12% -$54.6K 0.15% 85
2024
Q4
$426K Sell
2,400
-386
-14% -$71K 0.15% 89
2024
Q3
$550K Sell
2,786
-1,000
-26% -$187K 0.19% 86
2024
Q2
$649K Sell
3,786
-63
-2% -$10.4K 0.25% 78
2024
Q1
$701K Buy
3,849
+34
+0.9% +$5.86K 0.28% 73
2023
Q4
$591K Buy
3,815
+139
+4% +$20.3K 0.24% 73
2023
Q3
$548K Buy
3,676
+35
+1% +$5.14K 0.25% 72
2023
Q2
$490K Sell
3,641
-359
-9% -$52.6K 0.23% 73
2023
Q1
$637K Sell
4,000
-66,000
-94% -$10.1M 0.28% 70
2022
Q4
$1.13M Buy
+70,000
New +$10.7M 0.47% 59
2016
Q3
Sell
-3,100
Closed -$192 82
2016
Q2
$192 Sell
3,100
-2,000
-39% -$122K 0.05% 80
2016
Q1
$291K Buy
5,100
+500
+11% +$27.9K 0.14% 71
2015
Q4
$272K Buy
4,600
+1,500
+48% +$86.4K 0.13% 73
2015
Q3
$169K Hold
3,100
0.08% 80
2015
Q2
$208K Buy
+3,100
New +$202K 0.09% 72

Other funds holding ABBV